Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$229.11
+1.0%
$217.28
$163.81
$244.81
$405.41B0.516.45 million shs1.04 million shs
Anthem Inc stock logo
ANTM
Anthem
$0.00
$355.43
$533.68
$116.34BN/A1.21 million shs1.27 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$192.70
+0.3%
$180.09
$140.68
$194.40
$464.03B0.48.91 million shs2.23 million shs
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$353.91
-0.8%
$327.27
$234.60
$630.73
$320.88B0.4712.54 million shs2.41 million shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
+0.20%-1.84%+4.86%+19.82%+19.06%
Anthem Inc stock logo
ANTM
Anthem
0.00%0.00%0.00%0.00%0.00%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.43%+0.43%+8.68%+17.20%+16.75%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
-1.40%-3.25%+4.76%+25.94%-37.73%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$229.11
+1.0%
$217.28
$163.81
$244.81
$405.41B0.516.45 million shs1.04 million shs
Anthem Inc stock logo
ANTM
Anthem
$0.00
$355.43
$533.68
$116.34BN/A1.21 million shs1.27 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$192.70
+0.3%
$180.09
$140.68
$194.40
$464.03B0.48.91 million shs2.23 million shs
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$353.91
-0.8%
$327.27
$234.60
$630.73
$320.88B0.4712.54 million shs2.41 million shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
+0.20%-1.84%+4.86%+19.82%+19.06%
Anthem Inc stock logo
ANTM
Anthem
0.00%0.00%0.00%0.00%0.00%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.43%+0.43%+8.68%+17.20%+16.75%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
-1.40%-3.25%+4.76%+25.94%-37.73%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AbbVie Inc. stock logo
ABBV
AbbVie
2.74
Moderate Buy$234.052.16% Upside
Anthem Inc stock logo
ANTM
Anthem
0.00
N/AN/AN/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.73
Moderate Buy$199.593.57% Upside
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
2.46
Hold$384.098.53% Upside

Current Analyst Ratings Breakdown

Latest ANTM, JNJ, ABBV, and UNH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/17/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$250.00
10/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$210.00
10/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$174.00 ➝ $209.00
10/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$190.00
10/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$165.00 ➝ $190.00
10/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$213.00 ➝ $215.00
10/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$198.00 ➝ $204.00
10/14/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
10/14/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$190.00 ➝ $214.00
10/14/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Erste Group Bank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuyHold
10/14/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$406.00
(Data available from 10/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AbbVie Inc. stock logo
ABBV
AbbVie
$56.33B7.18$15.12 per share15.15$1.90 per share120.58
Anthem Inc stock logo
ANTM
Anthem
N/AN/AN/AN/AN/AN/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B5.23$13.23 per share14.57$29.69 per share6.49
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$400.28B0.80$31.74 per share11.15$106.78 per share3.31
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AbbVie Inc. stock logo
ABBV
AbbVie
$4.28B$2.10109.2816.391.416.45%699.66%13.64%10/31/2025 (Estimated)
Anthem Inc stock logo
ANTM
Anthem
N/A$32.5414.83N/AN/AN/AN/AN/AN/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$9.3518.6017.412.4027.26%33.08%13.30%N/A
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$14.41B$23.0815.3510.652.335.04%23.32%7.66%10/28/2025 (Estimated)

Latest ANTM, JNJ, ABBV, and UNH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/31/2025Q3 2025
AbbVie Inc. stock logo
ABBV
AbbVie
$3.26N/AN/AN/A$15.58 billionN/A
10/28/2025Q3 2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$2.87N/AN/AN/A$113.19 billionN/A
10/14/2025Q3 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.76$2.80+$0.04$2.12$23.73 billion$23.99 billion
7/31/2025Q2 2025
AbbVie Inc. stock logo
ABBV
AbbVie
$3.24$2.97-$0.27$0.52$14.93 billion$15.42 billion
7/29/2025Q2 2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$4.45$4.08-$0.37$3.74$111.75 billion$111.62 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AbbVie Inc. stock logo
ABBV
AbbVie
$6.562.86%N/A312.38%53 Years
Anthem Inc stock logo
ANTM
Anthem
$5.121.06%N/A15.73%N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.202.70%N/A55.61%64 Years
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$8.842.50%N/A38.30%15 Years

Latest ANTM, JNJ, ABBV, and UNH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/14/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.302.72%11/25/202511/25/202512/9/2025
9/5/2025
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.642.9%10/15/202510/15/202511/14/2025
8/13/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
quarterly$2.212.54%9/15/20259/15/20259/23/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AbbVie Inc. stock logo
ABBV
AbbVie
44.14
0.74
0.61
Anthem Inc stock logo
ANTM
Anthem
N/AN/AN/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.50
1.01
0.76
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.73
0.85
0.85

Institutional Ownership

CompanyInstitutional Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
70.23%
Anthem Inc stock logo
ANTM
Anthem
N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
87.86%

Insider Ownership

CompanyInsider Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
0.25%
Anthem Inc stock logo
ANTM
Anthem
N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
55,0001.77 billion1.76 billionOptionable
Anthem Inc stock logo
ANTM
Anthem
N/A241.09 millionN/AOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,1002.41 billion2.40 billionOptionable
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
400,000905.67 million903.14 millionOptionable

Recent News About These Companies

We Think UnitedHealth Group (NYSE:UNH) Can Stay On Top Of Its Debt
UnitedHealth's Path To Redemption: A Buy Amid The Storm
UnitedHealth Group (NYSE:UNH) Trading Down 1.5% - Time to Sell?
Here’s What Lifted UnitedHealth Group (UNH) in Q3
Here’s What Lifted UnitedHealth Group (UNH) in Q3

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AbbVie stock logo

AbbVie NYSE:ABBV

$229.10 +2.24 (+0.99%)
As of 11:13 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Anthem stock logo

Anthem NYSE:ANTM

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The firm supports consumers, families, and communities across the entire care journeyconnecting them to the care, support, and resources they need to lead healthier lives. It offers health plans and clinical, behavioral, pharmacy, and complex-care solutions which promote whole health. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$192.70 +0.58 (+0.30%)
As of 11:13 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

UnitedHealth Group stock logo

UnitedHealth Group NYSE:UNH

$353.90 -2.77 (-0.78%)
As of 11:13 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.